Dr. Davood Vafai
Claim this profileEisenhower Medical Center
Area of expertise
Lung Cancer
Davood Vafai has run 4 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Davood Vafai has run 3 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Eisenhower Medical Center
Eisenhower Army Medical Center
Clinical Trials Davood Vafai is currently running
Pirtobrutinib vs Ibrutinib
for Chronic Lymphocytic Leukemia
The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment for their cancer. The purpose of Part 2 of this study evaluates pirtobrutinib monotherapy in treatment-naïve participants with CLL/SLL with 17p deletions. Participation could last up to six years for Part 1. Participation could last up to 2 years for Part 2.
Recruiting
2 awards
Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Davood Vafai
Clinical Trial Related
11 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Davood Vafai has experience with
- Pembrolizumab
- Biospecimen Collection
- Crizotinib
- Carboplatin
- Gemcitabine Hydrochloride
- Paclitaxel
Breakdown of trials Davood Vafai has run
Lung Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Davood Vafai specialize in?
Davood Vafai focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Davood Vafai currently recruiting for clinical trials?
Yes, Davood Vafai is currently recruiting for 2 clinical trials in Rancho Mirage California. If you're interested in participating, you should apply.
Are there any treatments that Davood Vafai has studied deeply?
Yes, Davood Vafai has studied treatments such as Pembrolizumab, Biospecimen Collection, Crizotinib.
What is the best way to schedule an appointment with Davood Vafai?
Apply for one of the trials that Davood Vafai is conducting.
What is the office address of Davood Vafai?
The office of Davood Vafai is located at: Eisenhower Medical Center, Rancho Mirage, California 92270 United States. This is the address for their practice at the Eisenhower Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.